These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms]. Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400 [TBL] [Abstract][Full Text] [Related]
3. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance. Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208 [TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276 [TBL] [Abstract][Full Text] [Related]
5. SPM-1-producing Pseudomonas aeruginosa: analysis of the ancestor relationship using multilocus sequence typing, pulsed-field gel electrophoresis, and automated ribotyping. Silva FM; Carmo MS; Silbert S; Gales AC Microb Drug Resist; 2011 Jun; 17(2):215-20. PubMed ID: 21332364 [TBL] [Abstract][Full Text] [Related]
6. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-beta-lactamase in a hospital located in Rio de Janeiro, Brazil. Carvalho AP; Albano RM; de Oliveira DN; Cidade DA; Teixeira LM; Marques Ede A Microb Drug Resist; 2006; 12(2):103-8. PubMed ID: 16922625 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099 [TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of SPM-1-producing Pseudomonas aeruginosa by rep-PCR in hospitals in Parana, Brazil. Kalluf KO; Arend LN; Wuicik TE; Pilonetto M; Tuon FF Infect Genet Evol; 2017 Apr; 49():130-133. PubMed ID: 27923770 [TBL] [Abstract][Full Text] [Related]
9. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment. Shen JL; Fang YP Genet Mol Res; 2015 Jun; 14(2):6723-32. PubMed ID: 26125881 [TBL] [Abstract][Full Text] [Related]
10. Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates. Fehlberg LC; Xavier DE; Peraro PP; Marra AR; Edmond MB; Gales AC Microb Drug Resist; 2012 Aug; 18(4):402-7. PubMed ID: 22455540 [TBL] [Abstract][Full Text] [Related]
11. Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital. Liu Y; Li XY; Wan LG; Jiang WY; Li FQ; Yang JH Microb Drug Resist; 2013 Dec; 19(6):463-8. PubMed ID: 23865862 [TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals. Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of carbapenem resistance in endemic Pseudomonas aeruginosa isolates after an SPM-1 metallo-β-lactamase producing strain subsided in an intensive care unit of a teaching hospital in Brazil. Cacci LC; Chuster SG; Martins N; Carmo PR; Girão VB; Nouér SA; Freitas WV; Matos JA; Magalhães AC; Ferreira AL; Picão RC; Moreira BM Mem Inst Oswaldo Cruz; 2016 Sep; 111(9):551-8. PubMed ID: 27653359 [TBL] [Abstract][Full Text] [Related]
14. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele. Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722 [TBL] [Abstract][Full Text] [Related]
15. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France. Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169 [TBL] [Abstract][Full Text] [Related]
16. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil. Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284 [TBL] [Abstract][Full Text] [Related]
17. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil. Martins AF; Zavascki AP; Gaspareto PB; Barth AL Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208 [TBL] [Abstract][Full Text] [Related]
19. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients. Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825 [TBL] [Abstract][Full Text] [Related]
20. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]